Prognostic value of soluble interleukin 2 receptor levels in Langerhans cell histiocytosis

British Journal of Haematology

Volumn 117, Issue 1, 2002, Pages 54-58

  Rosso, Diego A ^a,b   Roy, Adriana ^a   Zelazko, Marta ^a   Braier, Jorge L ^a  

^a Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

^b Dublin 4272 ^*  (Argentina)

Author keywords

Childhood; Infant; Langerhans cell histiocytosis; Prognosis; Soluble inter leukin 2 receptor

Indexed keywords

INDOMETACIN; INTERLEUKIN 2 RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTIOCYTOSIS X; HUMAN; INFANT; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE;

ADOLESCENT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, INTERLEUKIN-2; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 0036223612     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03400.x     Document Type: Article

References (11)

1. Histio-cytosis X Langerhans cells react with antiinterleukin-2 receptor monoclonal antibody
2. Langerhans Cell Histiocytosis: Retrospective evaluation of 123 patients at a single institution
3. Current therapy for Langerhans cell histiocytosis
4. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment
5. Soluble cytokines receptors: Their roles in immunoregulation, disease, and therapy
6. Interleukin-2 receptor signaling mechanisms
7. Elevated soluble interleukin-2 receptor in childhood hemophagocytic syndromes
8. The epidemiology of Langerhans cell histiocytosis
9. Nosology and pathology of Langerhans cell histiocytosis
10. Langerhans cell Histiocytosis in children: Does interleukin-2-receptor correlate with both disease extent and activity?
11. The IL-2/IL-2 receptor system: A target for rational immune intervention